vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and MASIMO CORP (MASI). Click either name above to swap in a different company.
MASIMO CORP is the larger business by last-quarter revenue ($371.5M vs $236.8M, roughly 1.6× CROSS COUNTRY HEALTHCARE INC). MASIMO CORP runs the higher net margin — -27.0% vs -35.0%, a 8.0% gap on every dollar of revenue. On growth, CROSS COUNTRY HEALTHCARE INC posted the faster year-over-year revenue change (-23.6% vs -26.4%). MASIMO CORP produced more free cash flow last quarter ($50.9M vs $16.1M). Over the past eight quarters, MASIMO CORP's revenue compounded faster (-17.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.
CCRN vs MASI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $371.5M |
| Net Profit | $-82.9M | $-100.4M |
| Gross Margin | — | 62.1% |
| Operating Margin | -30.2% | 22.5% |
| Net Margin | -35.0% | -27.0% |
| Revenue YoY | -23.6% | -26.4% |
| Net Profit YoY | -2109.7% | -1124.5% |
| EPS (diluted) | $-2.56 | $-1.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | — | ||
| Q3 25 | $250.1M | $371.5M | ||
| Q2 25 | $274.1M | $370.9M | ||
| Q1 25 | $293.4M | $372.0M | ||
| Q4 24 | $309.9M | $600.7M | ||
| Q3 24 | $315.1M | $504.6M | ||
| Q2 24 | $339.8M | $496.3M | ||
| Q1 24 | $379.2M | $492.8M |
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $-100.4M | ||
| Q2 25 | $-6.7M | $51.3M | ||
| Q1 25 | $-490.0K | $-170.7M | ||
| Q4 24 | $-3.8M | $-349.6M | ||
| Q3 24 | $2.6M | $9.8M | ||
| Q2 24 | $-16.1M | $16.0M | ||
| Q1 24 | $2.7M | $18.9M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | 62.1% | ||
| Q2 25 | 20.4% | 62.9% | ||
| Q1 25 | 20.0% | 62.9% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | 20.4% | 52.2% | ||
| Q2 24 | 20.8% | 51.3% | ||
| Q1 24 | 20.4% | 49.0% |
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | 22.5% | ||
| Q2 25 | -2.1% | 17.4% | ||
| Q1 25 | -0.3% | 21.0% | ||
| Q4 24 | -1.1% | -59.8% | ||
| Q3 24 | 0.9% | 6.0% | ||
| Q2 24 | -5.7% | 5.7% | ||
| Q1 24 | 0.8% | 6.9% |
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | -27.0% | ||
| Q2 25 | -2.4% | 13.8% | ||
| Q1 25 | -0.2% | -45.9% | ||
| Q4 24 | -1.2% | -58.2% | ||
| Q3 24 | 0.8% | 1.9% | ||
| Q2 24 | -4.7% | 3.2% | ||
| Q1 24 | 0.7% | 3.8% |
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | $-1.84 | ||
| Q2 25 | $-0.20 | $0.94 | ||
| Q1 25 | $-0.02 | $-3.12 | ||
| Q4 24 | $-0.13 | $-6.54 | ||
| Q3 24 | $0.08 | $0.18 | ||
| Q2 24 | $-0.47 | $0.29 | ||
| Q1 24 | $0.08 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $312.3M |
| Total DebtLower is stronger | — | $559.1M |
| Stockholders' EquityBook value | $322.8M | $810.0M |
| Total Assets | $449.0M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | $312.3M | ||
| Q2 25 | $81.2M | $149.6M | ||
| Q1 25 | $80.7M | $130.8M | ||
| Q4 24 | $81.6M | $177.6M | ||
| Q3 24 | $64.0M | $158.5M | ||
| Q2 24 | $69.6M | $129.6M | ||
| Q1 24 | $5.2M | $157.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $559.1M | ||
| Q2 25 | — | $613.7M | ||
| Q1 25 | — | $651.0M | ||
| Q4 24 | — | $765.2M | ||
| Q3 24 | — | $772.6M | ||
| Q2 24 | — | $781.6M | ||
| Q1 24 | — | $876.0M |
| Q4 25 | $322.8M | — | ||
| Q3 25 | $408.1M | $810.0M | ||
| Q2 25 | $412.2M | $1.0B | ||
| Q1 25 | $418.2M | $946.4M | ||
| Q4 24 | $419.0M | $1.1B | ||
| Q3 24 | $424.7M | $1.5B | ||
| Q2 24 | $433.3M | $1.4B | ||
| Q1 24 | $462.4M | $1.4B |
| Q4 25 | $449.0M | — | ||
| Q3 25 | $538.2M | $1.8B | ||
| Q2 25 | $553.8M | $2.4B | ||
| Q1 25 | $576.2M | $2.3B | ||
| Q4 24 | $589.3M | $2.6B | ||
| Q3 24 | $597.4M | $3.1B | ||
| Q2 24 | $602.9M | $2.9B | ||
| Q1 24 | $648.4M | $3.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.64× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $56.8M |
| Free Cash FlowOCF − Capex | $16.1M | $50.9M |
| FCF MarginFCF / Revenue | 6.8% | 13.7% |
| Capex IntensityCapex / Revenue | 0.9% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $191.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | — | ||
| Q3 25 | $20.1M | $56.8M | ||
| Q2 25 | $4.2M | $69.4M | ||
| Q1 25 | $5.7M | $31.1M | ||
| Q4 24 | $24.2M | $50.5M | ||
| Q3 24 | $7.5M | $25.6M | ||
| Q2 24 | $82.4M | $74.5M | ||
| Q1 24 | $6.0M | $45.8M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | $50.9M | ||
| Q2 25 | $2.3M | $65.6M | ||
| Q1 25 | $3.8M | $28.5M | ||
| Q4 24 | $21.7M | $46.0M | ||
| Q3 24 | $6.3M | $16.9M | ||
| Q2 24 | $79.6M | $66.9M | ||
| Q1 24 | $3.8M | $37.6M |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | 13.7% | ||
| Q2 25 | 0.8% | 17.7% | ||
| Q1 25 | 1.3% | 7.7% | ||
| Q4 24 | 7.0% | 7.7% | ||
| Q3 24 | 2.0% | 3.3% | ||
| Q2 24 | 23.4% | 13.5% | ||
| Q1 24 | 1.0% | 7.6% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.6% | 0.7% | ||
| Q4 24 | 0.8% | 0.7% | ||
| Q3 24 | 0.4% | 1.7% | ||
| Q2 24 | 0.8% | 1.5% | ||
| Q1 24 | 0.6% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 2.61× | ||
| Q2 24 | — | 4.66× | ||
| Q1 24 | 2.23× | 2.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
MASI
Segment breakdown not available.
